Biotron Net Income vs. Number Of Employees

BITRF Stock  USD 0.06  0.00  0.00%   
Considering Biotron's profitability and operating efficiency indicators, Biotron Limited may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in June. Profitability indicators assess Biotron's ability to earn profits and add value for shareholders.
For Biotron profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biotron to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biotron Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biotron's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biotron Limited over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Biotron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biotron Limited Number Of Employees vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Biotron's current stock value. Our valuation model uses many indicators to compare Biotron value to that of its competitors to determine the firm's financial worth.
Biotron Limited is number one stock in net income category among related companies. It is number one stock in number of employees category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biotron by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biotron's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotron's earnings, one of the primary drivers of an investment's value.

Biotron Number Of Employees vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Biotron

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(2.78 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Biotron

Number of Employees

 = 

Full Time

+

Part Time

 = 
10
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.

Biotron Number Of Employees vs Competition

Biotron Limited is number one stock in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 1,046. Biotron maintains roughly 10.0 in number of employees contributing less than 1% to stocks in Biotechnology industry.

Biotron Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Biotron, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biotron will eventually generate negative long term returns. The profitability progress is the general direction of Biotron's change in net profit over the period of time. It can combine multiple indicators of Biotron, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Biotron operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Biotron Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Biotron. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biotron position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biotron's important profitability drivers and their relationship over time.

Use Biotron in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotron position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotron will appreciate offsetting losses from the drop in the long position's value.

Biotron Pair Trading

Biotron Limited Pair Trading Analysis

The ability to find closely correlated positions to Biotron could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotron when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotron - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotron Limited to buy it.
The correlation of Biotron is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotron moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotron Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotron can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Biotron position

In addition to having Biotron in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Restaurants Thematic Idea Now

Restaurants
Restaurants Theme
Entities that are involved in restaurant business, as well as coffee shop chains and other eateries. The Restaurants theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Restaurants Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for Biotron Pink Sheet analysis

When running Biotron's price analysis, check to measure Biotron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotron is operating at the current time. Most of Biotron's value examination focuses on studying past and present price action to predict the probability of Biotron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotron's price. Additionally, you may evaluate how the addition of Biotron to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
To fully project Biotron's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biotron Limited at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biotron's income statement, its balance sheet, and the statement of cash flows.
Potential Biotron investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Biotron investors may work on each financial statement separately, they are all related. The changes in Biotron's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biotron's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.